Friday, 16 Feb 2018

Today's Headlines

NHANES Survey Shows OA Rising and RA Declining

An analysis of 43,706 adults from the 1999-2014 National Health and Nutrition Examination Surveys (NHANES) demonstrated temporal trends in the prevalence of arthritis, including a rise in osteoarthritis (OA) from 6.6% to 14.3%, while the prevalence of rheumatoid arthritis (RA) decreased from 5.9% to 3.8% in the USA, (Citation source https://buff.ly/2o6fhkW

Abatacept Improves GvHD Outcomes

The results from a phase 2 clinical trial presented at the American Society of Hematology meeting demonstrated that the drug abatacept was highly effective in managing severe acute graft-versus-host disease (GvHD) in patients receiving hematopoietic stem cell transplants.

T2T Improves Primary Care Gout Management

Researchers from Geisinger Medical center tested a pilot primary care gout management improvement intervention, and demonstrated significantly improved primary care gout management metrics when a treat to target approach was implemented. 

DMARDs Lower Dementia Risk in Rheumatoid Arthritis

UK researchers have analyzed rheumatoid arthritis (RA) patients from the UK Clinical Practice Research Database and shown that chronic conventional DMARD (cDMARD) use was associated with 40% lower risk of dementia (nearly 50% with methotrexate use).

RWCS Day 4 Podcast

Listen in on the proceedings from the 2018 RWCS meeting in Maui, with excerpts from leading teachers in rheumatology. This podcast features presentations from Drs. Leslie Biello, Alvin Wells, Anne Stevens, Rachel Tate, Anna Postolova, Artie Kavanaugh, Bevra Hahn, Eric Ruderman, Mark Genovese, Uma Mahadevan, Bernie Rubin, Umber Ahmad. Listen here or on Stitcher, iTune, iPhone, Soundcloud or Google play. 

RWCS Day 3 Podcast

Listen in on the proceedings from the 2018 RWCS meeting in Maui with excerpts from leading teachers in rheumatology. This podcast features topics in dermatology, the fellowship program lead by Dr. Bernie Rubin and videos by the fellows.  Featured are Drs. Rachel Tate, Sheetal Patel, Bernie Rubin, Natasha Zohuri, Laura Howe, Kyle Maier, Jeff Chwa, George Martin, and Elaine Alexander.

BLOG

“It’s unbelievable how much you don’t know about the game you’ve been playing all your life.” - Mickey Mantle.

What I know and learned is often the subject of blogs on RheumNow. Yet, I’ve always been challenged and irked by what I don’t know.

Angie is my last patient before lunch. I've known her since her RA diagnosis at age 17 years. And for the last 7 years, she’s matured into a fabulous young woman who has adeptly grown her professional life, her dating life and developed her independence, despite her severely active rheumatoid arthritis. But today I see she has a troubled and anxious look as I greet her. 

Almost everyone gets their education about drug-related infection risk from television ads. Rheumatologists should know what the real risks are and educate their patients that they have a higher than normal rate of nonserious infections. But the infection risk is way more related to inflammation than any specific drug risk.

The antiphospholipid syndrome (APS) is a common disorder affecting patients with and without autoimmune disease. Despite wider recognition of APS among physicians as well as the expanding research collaborations, many clinical questions are still encountered in clinical practice, which require further evidence-based studies. In this “Across the Table” edition, Drs. Cush and Erkan discuss some of these APS-related questions. Our guest expert, Dr. Doruk Erkan offers up his approach to diagnosis and management of APS.

This rant is addressed to the Internet, all worldly publications, the ACR/ARHP, and our good frie

Dr. Bevra Hahn: Preventing Atherosclerosis in People with Rheumatic Disease
Dr. Bevra Hahn discusses how to prevent atherosclerosis in patients with rheumatic disease at the 2018 RWCS Meeting in Maui.
/vef/load/9eb7f2051fd9595dfc0a5e9de9d6906b?width=640&height=365

Social

Daily Download

How Rheumatologists Diagnose and Treat RA